The Edit Review: GLP-1 Prices, Care, and Subscription Questions

The Edit publishes introductory and ongoing prices before you start its medical intake. Its current treatment list shows compounded semaglutide at $200 for the first month, then $259 a month, and tirzepatide at $300 for the first month, then $349 a month. That distinction matters more for budgeting than the introductory offer alone.¹

Our assessment is based on the company's public information read in October 2026. It is a review of the service and its published terms, not a report of receiving treatment.

What do you get?

The service begins with choosing a treatment and completing a private health intake. A licensed provider reviews the information and determines whether a prescription is appropriate. The Edit lists compounded GLP-1 treatment alongside other prescription services; choosing an option does not guarantee approval.¹

For a prospective patient, the useful question is what happens after the initial decision: how refills are approved, how dose changes are discussed, and how to contact the clinical team between appointments. Get those details before comparing the program with a service offering more frequent scheduled visits.

How much does The Edit cost after the first month?

At the listed rates, twelve months of semaglutide would total $3,049: $200 plus eleven payments of $259. Twelve months of tirzepatide would total $4,139: $300 plus eleven payments of $349. Those are illustrations of the published schedule, not an individual quote; they assume unchanged prices and uninterrupted treatment.¹

The introductory discount therefore saves $59 or $49 once. It does not reduce every later payment. Ask whether the quote includes all doses, supplies, shipping, follow-up, and any required laboratory work. If an extra charge applies, add it to the total before comparing providers.

What should you clarify about care and availability?

The Edit says availability can vary with state, treatment, and pharmacy requirements. It also explicitly states that the compounded medications are not FDA-approved. Before paying, confirm that your state and the specific formulation are eligible and obtain the dispensing pharmacy's name.¹

Keep the clinical decision separate from the purchase decision. FDA advises that compounded drugs should be used only when a patient's needs cannot be met by an available approved drug. The prescriber should be able to explain why the proposed option fits your circumstances.²

Who is this service likely to suit?

It may appeal to someone who wants to see the first-month and continuing costs before sharing health information and prefers an online intake. It is less attractive if you need a fully documented annual budget but have not yet received answers about dose-related fees, labs, or cancellation. Those unresolved details should remain questions, rather than assumptions that everything is included.

The published prices make an initial comparison possible. They do not establish treatment results, the quality of clinical follow-up, or how a service will handle a difficult refill. Ask about these directly and keep a copy of the answers.

Our assessment

The Edit's strongest feature for comparison shopping is its separate display of introductory and renewal prices. Budget from $259 or $349 for ongoing care, then verify the complete quote and billing terms. Compare other GLP-1 telehealth services and use the true monthly cost calculator to account for introductory offers. For digestive concerns, our GLP-1 gut-health guide can help frame questions for your clinician.